Grandview Asset Management LLC Has $372,000 Holdings in CVS Health Corporation $CVS

Grandview Asset Management LLC lessened its stake in shares of CVS Health Corporation (NYSE:CVS) by 15.6% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,400 shares of the pharmacy operator’s stock after selling 1,000 shares during the quarter. Grandview Asset Management LLC’s holdings in CVS Health were worth $372,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Bell Investment Advisors Inc grew its holdings in CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC increased its position in CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares during the last quarter. ORG Partners LLC raised its holdings in shares of CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares in the last quarter. Saudi Central Bank bought a new stake in shares of CVS Health in the first quarter valued at about $34,000. Finally, Livelsberger Financial Advisory bought a new stake in CVS Health during the second quarter worth $35,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Buying and Selling

In related news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director owned 22,156 shares in the company, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.22% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on CVS shares. Barclays boosted their price objective on shares of CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. UBS Group raised shares of CVS Health from a “neutral” rating to a “buy” rating and upped their price objective for the company from $67.00 to $79.00 in a report on Monday, August 18th. Robert W. Baird raised shares of CVS Health from a “neutral” rating to an “outperform” rating and increased their target price for the stock from $71.00 to $82.00 in a research note on Thursday, August 14th. Zacks Research lowered shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $78.00 price target on shares of CVS Health in a research report on Tuesday, August 26th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $78.25.

CVS Health Stock Performance

Shares of CVS stock opened at $75.80 on Friday. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $77.34. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The business’s fifty day simple moving average is $69.13 and its 200-day simple moving average is $66.99. The company has a market cap of $96.14 billion, a PE ratio of 21.17, a PEG ratio of 0.84 and a beta of 0.62.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The firm had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same period in the prior year, the firm posted $1.83 earnings per share. The business’s quarterly revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio is 74.30%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.